Microbio Co., Ltd.
TWO: 4128.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Tzen-Wen Chen
- Employees
- 577
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$8.8B
- Website
- https://www.microbio.com.tw
Loading 4128…
Loading profile data…Frequently asked questions about 4128
What does Microbio Co., Ltd. (4128.TWO) do?
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for ameliorating fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia and menstrual discomfort. Its pre-clinical stage products i...
Where does 4128.TWO trade?
Microbio Co., Ltd. (4128.TWO) trades on the Taipei Exchange.
What sector is 4128.TWO in?
Microbio Co., Ltd. (4128.TWO) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of Microbio Co., Ltd.?
Tzen-Wen Chen is the chief executive officer of Microbio Co., Ltd. (4128.TWO).
Where is Microbio Co., Ltd. headquartered?
Microbio Co., Ltd. is headquartered in Taiwan.
Does 4128.TWO pay a dividend?
Microbio Co., Ltd. (4128.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4128.TWO go public?
Microbio Co., Ltd. (4128.TWO) completed its initial public offering in 2007.